Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q2 2022 · 10-Q
Revenue$11.47M$11.47M+90.7% vs Q2 2021 Net Income$750.21K$750.21KN/M vs Q2 2021 EPS Diluted$0.34$0.34N/M vs Q2 2021 Operating Income$1,321,651+63,964.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,292,048N/M Margins · derivedOperating margin11.5%+11.5 pt vs Q2 2021
Net margin6.5%+17.8 pt vs Q2 2021
ended Jun 30, 2022 · filed Sep 19, 2022 · 81 d after period end